Gain the Advantages of a Continuous Biopharmaceutical Processing
Currently in biopharmaceutical production, process steps are traditionally executed in separated unit operations. Individual upstream and downstream process steps are not linked creating process inefficiencies, increased costs and possible product loss.
With the introduction of advanced technologies for biopharmaceutical production it is becoming increasingly easier and more advantageous to link the various unit operations needed to produce a biopharmaceutical into a continuous processing scheme.
The benefits of continuous processing are many. By increasing the efficiency, flexibility, agility and robustness of biopharmaceutical manufacturing due to the reduction of the number of steps and holds and utilizing smaller equipment and facilities, product quality can be greatly improved enabling real-time release.
In this video, executives from Thermo Fisher Scientific discuss this growing trend, the technologies that are enabling continuous biopharmaceutical manufacturing, and how their company is responding to the market with equipment and technical expertise.